Company: ADPT
Filing Date: 2025-03-03
Form Type: 10-K
Source: 0000950170-25-030913
Chunk: 1

Company: Adaptive Biotechnologies Corp
Filing Date: 2025-03-03
Form: 10-K
Item: Item 15
Chunk 1
---
(a)  The following documents are filed as part of this Annual Report on Form 10-K:

(1)   Financial Statements

See Index to Consolidated Financial Statements in Part II, Item 8 of this Annual Report on Form 10-K.

(2)   Financial Statement Schedules

All financial statement schedules have been omitted since the required information was not applicable or was not present in amounts sufficient to require submission of the schedules, or because the information required is included in the consolidated financial statements or the accompanying notes.

(3)   Exhibits

The exhibits listed in the following Index to Exhibits are filed, furnished or incorporated by reference as part of this Annual Report on Form 10-K.

Index to Exhibits

    Incorporated by Reference

    ExhibitNumber
    Exhibit Title
    Filed/FurnishedWith ThisReport
    Form
    File No.
    Exhibit
    Filing Date

    3.1
    Amended and Restated Articles of Incorporation
     
    8-K
    001-38957
    3.1
    7/1/2019

    3.2
    Amended and Restated Bylaws
     
    8-K
    001-38957
    3.2
    7/1/2019

    4.1
    Seventh Amended and Restated Investors' Rights Agreement among the Registrant and certain of its shareholders, dated May 30, 2019
     
    S-1
    333-231838
    4.1
    5/30/2019

    4.2
    Description of Securities
     
    10-K
    001-38957
    4.3
    2/26/2020

    10.1†
    Strategic Collaboration and License Agreement between Genentech, Inc. and the Registrant, dated December 19, 2018
     
    S-1
    333-231838
    10.1
    5/30/2019

    10.2
    Amended and Restated Side Letter Agreement among Viking Global Equities LP, Viking Global Equities II LP, VGE III Portfolio Ltd., Viking Long Fund Master Ltd. and the Registrant, dated May 8, 2019
     
    S-1
    333-231838